An investigation of Temperament and Character Inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder

被引:7
|
作者
Tomita, Tetsu [1 ]
Ishioka, Masamichi [1 ]
Kaneda, Ayako [1 ]
Sugawara, Norio [1 ]
Nakagami, Taku [1 ]
Nakamura, Kazuhiko [1 ]
Yasui-Furukori, Norio [1 ]
机构
[1] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368562, Japan
关键词
Temperament and Character Inventory; Prediction; Paroxetine treatment; Major depressive disorder; PERSONALITY-DISORDER; MOOD DISORDERS; POLYMORPHISMS; OUTPATIENTS; SEROTONIN; PROFILES; TRAITS; STATES; MODEL; TCI;
D O I
10.1016/j.jad.2014.04.076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Previous studies have reported associations between Temperament and Character Inventory (TCI) dimension scores and the response to treatment in patients with major depressive disorder (MDD). We aimed to determine which TCI items could predict the response to treatment with paroxetine in patients with MDD. Methods: Seventy-three patients were enrolled in this study. The participants were treated with 10-40 mg/day of paroxetine for six weeks; they then completed the TCI. The Montgomery-Asberg Depression Rating Scale (MADRS) was used to evaluate the patients. The participants were divided into two groups (responders and non-responders). We used a chi-squared test to identify the 10 items with the strongest association with treatment response from among all 240 items on the TCI, and we used a multiple logistic regression analysis to confirm the validity of these 10 items. Results: Among the TCI dimension scores, only the C score differed significantly between the two groups. We analyzed 10 models using each of the 10 best items. All the models significantly predicted treatment response. The TCI dimensions model also significantly predicted treatment response, but its predictive value was lower than those of the other 10 models. Limitations: The responders included the early responders. The results lacked information about responders whose responses were not predicted by the logistic regression models and TCI items. Conclusions: Some TCI items showed significant associations with the response to paroxetine treatment in the patients with MDD. Treatment response in patients with MDD may be predicted using only 10 items from the TCI. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 50 条
  • [31] Pharmacological treatment for insomnia in patients with major depressive disorder
    Brietzke, Elisa
    Vazquez, Gustavo H.
    Kang, Melody J. Y.
    Soares, Claudio N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (11) : 1341 - 1349
  • [32] CLOCK may Predict the Response to Fluvoxamine Treatment in Japanese Major Depressive Disorder Patients
    Kishi, Taro
    Kitajima, Tsuyoshi
    Ikeda, Masashi
    Yamanouchi, Yoshio
    Kinoshita, Yoko
    Kawashima, Kunihiro
    Okochi, Tomo
    Okumura, Takenori
    Tsunoka, Tomoko
    Ozaki, Norio
    Iwata, Nakao
    NEUROMOLECULAR MEDICINE, 2009, 11 (02) : 53 - 57
  • [33] DAOA Variants on Diagnosis and Response to Treatment in Patients with Major Depressive Disorder and Bipolar Disorder
    Chiesa, A.
    Pae, C-U
    Porcelli, S.
    Han, C.
    Lee, S-J
    Patkar, A. A.
    Park, M. H.
    Jun, T-Y
    Serretti, A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (01) : 258 - 265
  • [34] Use of the Temperament and Character Inventory to Predict Response to Repetitive Transcranial Magnetic Stimulation for Major Depression
    Siddiqi, Shan H.
    Chockalingam, Ravikumar
    Cloninger, C. Robert
    Lenze, Eric J.
    Cristancho, Pilar
    JOURNAL OF PSYCHIATRIC PRACTICE, 2016, 22 (03) : 193 - 202
  • [35] Temperament and character as a predictor of response to selective serotonin reuptake inhibitors in patients with majordepressive disorder
    Sakhvidi, Mohammad Nadi
    Shayegh, Samira
    Hosseini, Fatemeh
    Zadeh, Golrasteh Kholaseh
    Bozorg, Bonnie
    Salimi, Zanireh
    Amini, Fariba
    Namdari, Mahshid
    Bidaki, Reza
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2022, 24 (03): : 25 - 31
  • [36] Beneficial Effects of Acupuncture as a Complementary Treatment for Patients Receiving Paroxetine For Major Depressive Disorder: A Meta-Analysis
    Nguyen, Minh Duc
    Nguyen, Quoc Vinh
    Ha, Cay Doan
    Van Tran, Thanh
    Dang, Linh Vu Phuong
    MEDICAL ACUPUNCTURE, 2021, 33 (06) : 420 - 427
  • [37] Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
    Perahia, D. G. S.
    Wang, F.
    Mallinckrodt, C. H.
    Walker, D. J.
    Detke, M. J.
    EUROPEAN PSYCHIATRY, 2006, 21 (06) : 367 - 378
  • [38] Investigation of Irisin Levels in Patients with Major Depressive Disorder
    Okumus, Burak
    Pusuroglu, Meltem
    Baltacioglu, Mehmet
    Bahceci, Ilkay
    Bahceci, Buelent
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2024, 14 (01): : 40 - 47
  • [39] Inflammatory cytokines, cognition, and response to antidepressant treatment in patients with major depressive disorder
    Zhou, Qi
    Lv, Xiaozhen
    Zhou, Shuzhe
    Liu, Qi
    Tian, Hongjun
    Zhang, Kerang
    Wei, Jing
    Wang, Gang
    Chen, Qiaoling
    Zhu, Gang
    Wang, Xueyi
    An, Cuixia
    Zhang, Nan
    Huang, Yu
    Si, Tianmei
    Yu, Xin
    Shi, Chuan
    PSYCHIATRY RESEARCH, 2021, 305
  • [40] An attempt to construct a 7-item short version of the temperament and character inventory to predict the treatment response of patients with depression; a validation study
    Tetsu Tomita
    Norio Yasui-Furukori
    Ayako Kaneda
    Masamichi Ishioka
    Norio Sugawara
    Taku Nakagami
    Kazuhiko Nakamura
    BMC Psychiatry, 16